Diabetic macular edema (DME)
Conditions
Interventions
Control group:Use routine nursing methods
Experimental group :All patients were treated with T&E anti-VEGF infusion after routine care
To establish diabetic retinopathy treatment and intervention group
Sponsors
The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for diabetic macular edema outlined in the *Clinical Practice Guidelines for Diabetic Retinopathy (2022)*. 2. Patients aged 18 years or older, including individuals aged 75 years and above, without psychiatric disorders and demonstrating good compliance. 3. Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with severe complications, such as vitreous hemorrhage, neovascular glaucoma, requiring vitrectomy, or having received anti-VEGF injections prematurely. 2. Patients with psychiatric disorders or communication impairments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual acuity improved significantly;The severity score of diabetic optic membrane lesions decreased;The number of anti-VEGF drug injections decreased significantly within one year; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients' follow-up rate;Treatment compliance;Self-empowerment ;Satisfaction were significantly improved; | — |
Countries
China
Contacts
Public ContactLi Zhang
The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China
Outcome results
None listed